Date: 16-06-2009

Hyderabad-based pharmaceutical major Dr Reddy’s Laboratories (DRL) has entered into a partnership with GlaxoSmithKline (GSK) to develop and market select products across emerging markets outside India. Under the terms of the agreement, which is effective immediately, GSK will gain access to DRL’s diverse portfolio and a pipeline of more than 100 branded pharmaceuticals in fast-growing therapeutic segments, such as cardiovascular, diabetes, oncology, gastroenterology and pain management.

 

The products will be manufactured by DRL and will be licensed and supplied to GSK in various emerging markets such as Africa, West Asia, Latin America and Asia-Pacific, excluding India. Revenues will be reported by GSK and will be shared with DRL as per agreed terms. In certain markets, products will be co-marketed by DRL and GSK.

 

This is another significant step forward to grow and diversify business in emerging markets. Growth in both population and economic prosperity is leading to increased demand for branded pharmaceuticals. This new alliance will combine Dr Reddy’s portfolio of high quality branded pharmaceuticals together with GSK’s extensive sales and marketing capabilities.

crackcrack
Latest Financials

Latest Financials

 - Dr. Reddys Laboratories Ltd.

  Standalone Consolidated
TTM EPS (Rs) 76.89 117.39
TTM Sales (Rs. Cr.) 10,626 15,448
BVPS (Rs.)
The total value that a company will fetch upon liquidation (if it is closed down), after settling all obligations is called its Book Value. Book value of a company includes only tangible assets. Book value allocated to each outstanding share is called Book Value per share
758.8 839.43
Reserves (Rs. Cr.)
The term reserve represents a part of shareholders' equity, except for basic share capital. Reserves are created from retained earnings and shareholders' contributions in the form of share premium etc.
12,522 13,861
P/BV
Price to Book Value is the ratio of stock's market value to its book value. It gives some idea of whether investors are paying too much for what would be left if the company went bankrupt immediately. To get high returns, it is advisable to invest in a company which satisfies all the criteria set by MoneyWorks4me and which has low price to book value ratio.
3.42 3.09
PE
It is the ratio of market price and earnings per share. It shows what the market is willing to pay for the company's earnings. To get high returns it is advisable to invest in the company which satisfies all the criteria set by MoneyWorks4me and which has low price to earnings ratio as compared to the industry.
33.78 22.13
From the Market
52 Week High / Low (Rs) 2965.20/2035.00
All Time High / Low (Rs) 4382.95/6.25
Volume Traded 13,757
Market Cap (Rs. Cr.) 43,151
Equity (Rs. Cr.) 83.06
Face Value (Rs) 5
Industry PE
Industry price to earnings per share tells on an average, what the market is willing to pay for overall earnings in that industry. It can be used as a benchmark price to earnings ratio for the companies in that industry.
28.42
Return to Top
Puchho Befikar